ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 669,10
0,28%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Applied Therapeutics Inc (APLT)

  7. Applied Therapeutics Inc (APLT) Actualités

APLT Applied Therapeutics Inc

4,28
-0,12 (-2,73%)
31 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Applied Therapeutics Inc APLT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,12 -2,73% 4,28 22:51:28
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,40 4,26 4,475 4,28 4,40
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/5/202422:37EDGAR2Form 144 - Report of proposed sale of securities
17/5/202400:10EDGAR2Form 144 - Report of proposed sale of securities
09/5/202413:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:13EDGAR2Form 8-K - Current report
09/5/202413:00GLOBEApplied Therapeutics Reports First Quarter 2024 Financial..
07/5/202413:00GLOBEApplied Therapeutics to Present at the 2024 RBC Capital..
15/4/202413:00GLOBEApplied Therapeutics Appoints Dale Hooks as Chief Commercial..
04/4/202413:00GLOBEApplied Therapeutics to Present Results from Phase 3..
28/3/202421:30GLOBEApplied Therapeutics Provides FDA Update on PDUFA Target..
11/3/202413:17EDGAR2Form 8-K - Current report
06/3/202413:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:12EDGAR2Form 8-K - Current report
06/3/202413:00GLOBEApplied Therapeutics Reports Fourth Quarter and Year-end..
05/3/202423:42EDGAR2Form SC 13D/A - General statement of acquisition of..
29/2/202422:18EDGAR2Form 8-K - Current report
28/2/202414:05GLOBEApplied Therapeutics Announces $100 Million Private..
28/2/202414:00GLOBEApplied Therapeutics Announces FDA Acceptance and Priority..
22/2/202420:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202413:07EDGAR2Form 8-K - Current report
15/2/202413:00GLOBEApplied Therapeutics Announces Positive Results from..
15/2/202403:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202423:02EDGAR2Form 8-K - Current report
04/1/202422:05GLOBEApplied Therapeutics Announces Topline Results from the..
03/1/202417:20DJNApplied Therapeutics Shares Hit 52-Week High on Govorestat..
03/1/202415:15EDGAR2Form 8-K - Current report
03/1/202413:00GLOBEApplied Therapeutics Announces MAA Validation and NDA..
29/12/202322:23EDGAR2Form 8-K - Current report
23/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202301:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:11EDGAR2Form 8-K - Current report
13/11/202323:10EDGAR2Form SC 13D/A - General statement of acquisition of..
09/11/202313:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:36EDGAR2Form 8-K - Current report
09/11/202313:30GLOBEApplied Therapeutics Reports Third Quarter 2023 Financial..
03/11/202321:37EDGAR2Form 144 - Report of proposed sale of securities
02/11/202321:33EDGAR2Form 144 - Report of proposed sale of securities
02/11/202312:00GLOBEApplied Therapeutics to Present at the UBS Biopharma..
01/11/202321:42EDGAR2Form 144 - Report of proposed sale of securities
01/11/202312:00GLOBEApplied Therapeutics to Host Diabetic Cardiomyopathy Expert..
31/10/202321:42EDGAR2Form 144 - Report of proposed sale of securities
13/10/202322:42EDGAR2Form 8-K - Current report
30/9/202302:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
APLT
Applied Therapeutics
USOTC
GSOL
Grayscale Solana Trust SOL (QX)
EU
FR0013066909
Republic of France O A T...
COIN
YFIKINGUSD
YFIKING,FINANCE
EU
3LST
Graniteshares 3x Long St...
BIT
UC2Q21
Unicredit Bank
BIT
F11980
Vontobel Financial Produ...
BOV
C2OL34M
Bancolombia
LSE
ZR28
Barclays 27
LSE
AJ45
State Is 34
BOV
TAKP34M
Takeda Pharmaceutical
LSE
FE89
Tor.dom.28
TSXV
TOM.H
Amilot Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés